Review
doi: 10.1002/pauz.200800282.
[Innovations with system disrupting potential? New drugs of high value]
[Article in
German]
Affiliations
- PMID: 18729265
- DOI: 10.1002/pauz.200800282
Item in Clipboard
Review
[Innovations with system disrupting potential? New drugs of high value]
[Article in
German]
Pharm Unserer Zeit.
2008.
No abstract available
Similar articles
-
Which tyrosine kinase inhibitor, if any?Clin Adv Hematol Oncol. 2011 Nov;9(11):878-9. Clin Adv Hematol Oncol. 2011. PMID: 22252622 Review. No abstract available.
-
[Inhibition of the VEGF receptor system with tyrosine kinase inhibitors. Angiogenesis inhibition in oncology].Pharm Unserer Zeit. 2008;37(5):404-15. doi: 10.1002/pauz.200800281. Pharm Unserer Zeit. 2008. PMID: 18729270 Review. German. No abstract available.
-
Structural biology contributions to tyrosine kinase drug discovery.Curr Opin Cell Biol. 2009 Apr;21(2):280-7. doi: 10.1016/j.ceb.2009.01.012. Epub 2009 Feb 7. Curr Opin Cell Biol. 2009. PMID: 19208462 Review.
-
Playing Russian roulette with tyrosine kinase inhibitors.Clin Pharmacol Ther. 2013 Mar;93(3):242-4. doi: 10.1038/clpt.2012.245. Epub 2012 Dec 18. Clin Pharmacol Ther. 2013. PMID: 23340477 No abstract available.
-
Tyrosine kinase inhibitors and gut toxicity: a new era in supportive care.Curr Opin Support Palliat Care. 2008 Mar;2(1):19-21. doi: 10.1097/SPC.0b013e3282f5273f. Curr Opin Support Palliat Care. 2008. PMID: 18685389 No abstract available.
Cited by
-
[Health services research in oncology using claims data].Med Klin (Munich). 2010 Jun;105(6):409-15. doi: 10.1007/s00063-010-1073-z. Epub 2010 Jun 26. Med Klin (Munich). 2010. PMID: 20582501 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
